Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)Completed
NCT04950127Phase 3Updated Jul 22, 2026
Sponsor: GlaxoSmithKline
Pruritus
Germany, United Kingdom
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsRecruiting
NCT07070232Phase 1, Phase 2Updated Jul 22, 2026
Sponsor: BioNTech SE
Advanced Solid Tumor
United States, Australia, Belgium, Germany, Italy +3 more
Study of INCA036978 in Participants With Myeloproliferative NeoplasmsRecruiting
NCT07441694Phase 1Updated Jul 22, 2026
Sponsor: Incyte Corporation
Myeloproliferative Neoplasms
United States, Australia, Belgium, Canada, France +6 more
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)Active Not Recruiting
NCT06814145Phase 2Updated Jul 22, 2026
Sponsor: Merck Sharp & Dohme LLC
Hypertension, Pulmonary
United States, Belgium, Canada, France, Germany +7 more
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D VirusCompleted
NCT04535544Phase 2Updated Jul 22, 2026
Sponsor: Janssen Research & Development, LLC
Hepatitis D, Chronic
United States, Australia, Brazil, China, France +10 more
A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisCompleted
NCT03896581Phase 3Updated Jul 22, 2026
Sponsor: UCB Biopharma SRL
Psoriatic Arthritis
United States, Australia, Canada, Czechia, Germany +6 more
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune DiseaseRecruiting
NCT07549698Phase 1, Phase 2Updated Jul 22, 2026
Sponsor: CRISPR Therapeutics AG
Warm Autoimmune Hemolytic Anemia (WAIHA) · ITP - Immune Thrombocytopenia · Warm Autoimmune Hemolytic Anemia · Immune Thrombocytopenic Purpura
United States, Germany, Spain
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung CancerRecruiting
NCT05142189Phase 1Updated Jul 22, 2026
Sponsor: BioNTech SE
Non-Small Cell Lung Cancer
United States, Australia, Germany, Hungary, Poland +3 more
Home-based Prehabilitation for Elderly PatientsCompleted
NCT03964363NAUpdated Jul 22, 2026
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Frail Elderly Syndrome
Germany
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesNot Yet Recruiting
NCT07648264Phase 3Updated Jul 22, 2026
Sponsor: CSL Behring
Secondary Immune Deficiency
United States, Belgium, Canada, Czechia, Denmark +6 more
Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C MutationCompleted
NCT05198934Phase 3Updated Jul 22, 2026
Sponsor: Amgen
Colorectal Cancer (CRC)
United States, Australia, France, Germany, Greece +7 more
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care SettingActive Not Recruiting
NCT06712563N/AUpdated Jul 22, 2026
Sponsor: AstraZeneca
Pulmonary Disease, Chronic Obstructive
Canada, Germany, Greece, Italy, Japan +2 more
A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisCompleted
NCT03895203Phase 3Updated Jul 22, 2026
Sponsor: UCB Biopharma SRL
Psoriatic Arthritis
United States, Australia, Belgium, Canada, Czechia +9 more
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerRecruiting
NCT05253651Phase 3Updated Jul 22, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms
United States, Argentina, Australia, Austria, Belgium +20 more
Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor BurdenNot Yet Recruiting
NCT07715396Phase 3Updated Jul 22, 2026
Sponsor: AIO-Studien-gGmbH
Non-small Cell Lung Cancer Metastatic
Germany
A Study to Assess NAV-240 in Adult Participants With Hidradenitis SuppurativaRecruiting
NCT07384975Phase 2Updated Jul 22, 2026
Sponsor: Navigator Medicines, Inc.
Hidradenitis Suppurativa (HS)
United States, Bulgaria, Canada, Georgia, Germany +3 more
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)Recruiting
NCT06371417Phase 1Updated Jul 22, 2026
Sponsor: Chugai Pharmaceutical
Antiphospholipid Syndrome (APS) · Bullous Pemphigoid (BP) · Behçet's Syndrome (BS) · Dermatomyositis (DM)
United States, Australia, Austria, Bulgaria, Canada +15 more
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKETerminated
NCT05746559Phase 3Updated Jul 22, 2026
Sponsor: Alexion Pharmaceuticals, Inc.
Chronic Kidney Disease · CKD · Cardiac Disease · Cardiopulmonary Bypass
United States, Argentina, Australia, Brazil, Canada +15 more
Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised LipodystrophyTerminated
NCT06502990Phase 3Updated Jul 22, 2026
Sponsor: Amryt Pharma
Generalized Lipodystrophy
Belgium, France, Germany, Italy
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)Active Not Recruiting
NCT05060016Phase 2Updated Jul 22, 2026
Sponsor: Amgen
Relapsed/Refractory Small Cell Lung Cancer
United States, Austria, Belgium, Denmark, France +13 more
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisRecruiting
NCT07250802Phase 3Updated Jul 21, 2026
Sponsor: Takeda
Plaque Psoriasis
United States, China, Germany, Italy, Japan +2 more
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination TherapyActive Not Recruiting
NCT05444257Phase 3Updated Jul 21, 2026
Sponsor: Vertex Pharmaceuticals Incorporated
Cystic Fibrosis
United States, Australia, Austria, Belgium, Canada +18 more
A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAODActive Not Recruiting
NCT05933200Phase 3Updated Jul 21, 2026
Sponsor: Ultragenyx Pharmaceutical Inc
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Czechia, Germany, Japan, Poland, Saudi Arabia +2 more
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory MyopathyEnrolling By Invitation
NCT05979441Phase 3Updated Jul 21, 2026
Sponsor: argenx
Myositis · Active Idiopathic Inflammatory Myopathy · Dermatomyositis · Polymyositis
United States, Argentina, Austria, Belgium, Bulgaria +24 more
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.Recruiting
NCT05421858Phase 3Updated Jul 21, 2026
Sponsor: Basilea Pharmaceutica
Candidemia · Candidiasis, Invasive
United States, Argentina, Australia, Austria, Belgium +15 more

Previous page Next page